For citations:

Rusakov I.G., Buharkin B.V., Ataev A.M., Vereshagin G.V. Docetaxel (Tautax) in the treatment of hormone-refractory prostate cancer. Cancer Urology. 2008;4(2):62-67. (In Russ.) https://doi.org/10.17650/1726-9776-2008-4-2-62-67